US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

CARGO Therapeutics

4.54

-0.0900-1.94%

Post-market: 4.540.00000.00%16:05 EDT

Volume:636.52K

Turnover:2.92M

Market Cap:209.08M

PE:-1.22

High:4.66

Open:4.65

Low:4.50

Close:4.63

Loading ...

Overview Company News Filings

CARGO Therapeutics Inc : Truist Securities Cuts Target Price to $7 From $32

THOMSON REUTERS

Truist Downgrades CARGO Therapeutics to Hold From Buy, Cuts Price Target to $7 From $32

MT Newswires Live

Cargo Therapeutics to Cut Workforce by 50%, Discontinue Lymphoma Treatment Study -- Shares Down Pre-Bell

MT Newswires Live

CARGO Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy

THOMSON REUTERS

CARGO Therapeutics Inc : JP Morgan Cuts to Underweight From Overweight

THOMSON REUTERS

CARGO Therapeutics Falls 75.4% Premarket After Co to Stop Development of Cancer Cell Therapy, Evaluate Strategic Options

THOMSON REUTERS

CARGO Therapeutics Cut to Neutral From Buy by Chardan Capital

CARGO Therapeutics, Inc. (CRGX) was downgraded to a Hold Rating at William Blair

CARGO Therapeutics Inc : Jefferies Cuts to Hold From Buy

THOMSON REUTERS

CARGO Therapeutics Inc : Chardan Capital Markets Cuts to Neutral Rating

THOMSON REUTERS

Chardan Capital downgrades CARGO Therapeutics, Inc. (CRGX) to a Hold

Cargo Therapeutics to Lay Off 50% of Workers, Stop Developing Blood Cancer Treatment

CARGO Therapeutics Inc - Wind-Down Costs for Firi-Cel Program Expected to Total $7 Million to $10 Million

THOMSON REUTERS

CARGO Therapeutics Inc - Expects Cash Runway Extended Into Mid-2028

THOMSON REUTERS

CARGO Therapeutics: Believes Phase 2 Clinical Study of Firicabtagene Autoleucel Results Do Not Support Competitive Benefit-Risk Profile for Patients

THOMSON REUTERS

CARGO Therapeutics to Discontinue Firce-1 Phase 2 Study of Firi-Cel; Advances Remaining Programs While Evaluating Strategic Options

THOMSON REUTERS

CARGO Therapeutics Inc - Phase 1 Study Enrollment for Crg-023 to Start in Q2 2025

THOMSON REUTERS

CARGO Therapeutics Inc - to Reduce Workforce by Approximately 50%

THOMSON REUTERS

CARGO Therapeutics, Inc. (CRGX) Receives a Buy from Truist Financial

William Blair Keeps Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/CRGX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"CRGX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRGX\",,,,,undefined,":{"symbol":"CRGX","market":"US","secType":"STK","nameCN":"CARGO Therapeutics","latestPrice":4.54,"timestamp":1745956800000,"preClose":4.63,"halted":0,"volume":636517,"hourTrading":{"tag":"盘后","latestPrice":4.54,"preClose":4.54,"latestTime":"16:05 EDT","volume":1702,"amount":7727.08,"timestamp":1745957111060},"delay":0,"floatShares":31080301,"shares":46052368,"eps":-3.724779,"marketStatus":"Not Yet Opened","change":-0.09,"latestTime":"04-29 16:00:00 EDT","open":4.65,"high":4.655,"low":4.5,"amount":2922650.907,"amplitude":0.033477,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-3.724779,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746000000000},"marketStatusCode":0,"adr":0,"listingDate":1699592400000,"exchange":"NASDAQ","adjPreClose":4.63,"postHourTrading":{"tag":"盘后","latestPrice":4.54,"preClose":4.54,"latestTime":"16:05 EDT","volume":1702,"amount":7727.08,"timestamp":1745957111060},"volumeRatio":0.665625,"impliedVol":1.0563,"impliedVolPercentile":0.6214},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"CRGX\",,,,,undefined,":{"symbol":"CRGX","floatShares":31080301,"roa":"-27.01%","roe":"-43.76%","lyrEps":-3.724779,"volumeRatio":0.665625,"shares":46052368,"dividePrice":0,"high":4.655,"amplitude":0.033477,"preClose":4.63,"low":4.5,"week52Low":3,"pbRate":"0.58","week52High":25.45,"institutionHeld":0,"latestPrice":4.54,"eps":-3.724779,"divideRate":0,"volume":636517,"delay":0,"ttmEps":-3.724779,"open":4.65,"prevYearClose":14.42,"prevWeekClose":4.51,"prevMonthClose":4.07,"prevQuarterClose":4.07,"fiveDayClose":4.6,"twentyDayClose":4.07,"sixtyDayClose":3.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"CRGX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507641101","title":"CARGO Therapeutics Inc : Truist Securities Cuts Target Price to $7 From $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2507641101","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507641101?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:39","pubTimestamp":1738237160,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ12J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRGX","BK4139"],"gpt_icon":0},{"id":"2507649224","title":"Truist Downgrades CARGO Therapeutics to Hold From Buy, Cuts Price Target to $7 From $32","url":"https://stock-news.laohu8.com/highlight/detail?id=2507649224","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507649224?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:20","pubTimestamp":1738236040,"startTime":"0","endTime":"0","summary":"CARGO Therapeutics (CRGX) has an average rating of overweight and mean price target of $19.71, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRGX"],"gpt_icon":0},{"id":"2507649162","title":"Cargo Therapeutics to Cut Workforce by 50%, Discontinue Lymphoma Treatment Study -- Shares Down Pre-Bell","url":"https://stock-news.laohu8.com/highlight/detail?id=2507649162","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507649162?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:14","pubTimestamp":1738235676,"startTime":"0","endTime":"0","summary":"Cargo Therapeutics  said Wednesday that it will discontinue the phase 2 study of firicabtagene autoleucel, or firi-cel, for patients with large B-cell lymphoma, and reduce its workforce by about 50% to preserve cash for the development of other product candidates.The company said results from an ad-hoc analysis of the phase 2 study data \"do not support a competitive benefit-risk profile\" of firi-cel for the target patient population. The company will focus instead on advancing CRG-023 and its allogeneic platform, while evaluating its strategic options.Cargo Therapeutics said it targets to start enrollment for a phase 1 dose escalation study on CRG-023 in Q2.Cargo Therapeutics shares were down more than 74% in recent premarket activity Thursday.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["CRGX","LENZ","BK4139"],"gpt_icon":0},{"id":"2507649527","title":"CARGO Therapeutics, Inc. : H.c. Wainwright Cuts to Neutral From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2507649527","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507649527?lang=en_us&edition=fundamental","pubTime":"2025-01-30 19:10","pubTimestamp":1738235404,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nAZN39150K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507469696","title":"CARGO Therapeutics Inc : JP Morgan Cuts to Underweight From Overweight","url":"https://stock-news.laohu8.com/highlight/detail?id=2507469696","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507469696?lang=en_us&edition=fundamental","pubTime":"2025-01-30 18:58","pubTimestamp":1738234726,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ10J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRGX","BK4139"],"gpt_icon":0},{"id":"2507646634","title":"CARGO Therapeutics Falls 75.4% Premarket After Co to Stop Development of Cancer Cell Therapy, Evaluate Strategic Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2507646634","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507646634?lang=en_us&edition=fundamental","pubTime":"2025-01-30 18:52","pubTimestamp":1738234354,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nL3N3OQ0PY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507456276","title":"CARGO Therapeutics Cut to Neutral From Buy by Chardan Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2507456276","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507456276?lang=en_us&edition=fundamental","pubTime":"2025-01-30 18:25","pubTimestamp":1738232700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/CRGX/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  January 30, 2025 05:25 ET (10:25 GMT)","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRGX"],"gpt_icon":0},{"id":"2507645657","title":"CARGO Therapeutics, Inc. (CRGX) was downgraded to a Hold Rating at William Blair","url":"https://stock-news.laohu8.com/highlight/detail?id=2507645657","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507645657?lang=en_us&edition=fundamental","pubTime":"2025-01-30 18:17","pubTimestamp":1738232268,"startTime":"0","endTime":"0","summary":"CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from William Blair analyst Sami Corwin today. The company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cargo-therapeutics-inc-crgx-was-downgraded-to-a-hold-rating-at-william-blair?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cargo-therapeutics-inc-crgx-was-downgraded-to-a-hold-rating-at-william-blair?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRGX"],"gpt_icon":0},{"id":"2507061551","title":"CARGO Therapeutics Inc : Jefferies Cuts to Hold From Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2507061551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507061551?lang=en_us&edition=fundamental","pubTime":"2025-01-30 14:14","pubTimestamp":1738217694,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ0CT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRGX","BK4139"],"gpt_icon":0},{"id":"2507618065","title":"CARGO Therapeutics Inc : Chardan Capital Markets Cuts to Neutral Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2507618065","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507618065?lang=en_us&edition=fundamental","pubTime":"2025-01-30 13:42","pubTimestamp":1738215736,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250130:nFWN3OQ071:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507690755","title":"Chardan Capital downgrades CARGO Therapeutics, Inc. (CRGX) to a Hold","url":"https://stock-news.laohu8.com/highlight/detail?id=2507690755","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507690755?lang=en_us&edition=fundamental","pubTime":"2025-01-30 12:55","pubTimestamp":1738212906,"startTime":"0","endTime":"0","summary":"CARGO Therapeutics, Inc. (CRGX – Research Report) received a Hold rating and price target from Chardan Capital analyst Geulah Livshits yesterday. T...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/chardan-capital-downgrades-cargo-therapeutics-inc-crgx-to-a-hold?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/chardan-capital-downgrades-cargo-therapeutics-inc-crgx-to-a-hold?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRGX"],"gpt_icon":0},{"id":"2507669506","title":"Cargo Therapeutics to Lay Off 50% of Workers, Stop Developing Blood Cancer Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2507669506","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507669506?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:58","pubTimestamp":1738187880,"startTime":"0","endTime":"0","summary":"Shares of Cargo Therapeutics tumbled after the company said it will cut half of its workforce, or about 58 jobs, as it stops the development of one of its drugs.The stock fell 68%, to $4.41, in after-hours trading. Shares ended the regular session down 3.4%, at $13.19, having lost 40% of their value in the past year.The San Carlos, Calif., company said Wednesday that the job cuts will extend its cash runway, allowing it to prioritize focus on the development of other potential treatments.The job cuts come as Cargo Therapeutics discontinued the development of its potential treatment for certain types of blood cancer, citing results from a recent trial that don't support a competitive benefit-risk profile for the intended patient population.Cargo employed 116 people as of Dec. 31, 2023, according to its most recent annual report filed with the Securities and Exchange Commission.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LENZ","CRGX","BK4139"],"gpt_icon":0},{"id":"2507665005","title":"CARGO Therapeutics Inc - Wind-Down Costs for Firi-Cel Program Expected to Total $7 Million to $10 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2507665005","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507665005?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:31","pubTimestamp":1738186296,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nFWN3OP1OD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507663487","title":"CARGO Therapeutics Inc - Expects Cash Runway Extended Into Mid-2028","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663487","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507663487?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUAWSVKG:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507663146","title":"CARGO Therapeutics: Believes Phase 2 Clinical Study of Firicabtagene Autoleucel Results Do Not Support Competitive Benefit-Risk Profile for Patients","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663146","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507663146?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUAWSVKG:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507663127","title":"CARGO Therapeutics to Discontinue Firce-1 Phase 2 Study of Firi-Cel; Advances Remaining Programs While Evaluating Strategic Options","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663127","media":"THOMSON REUTERS","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507663127?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUAWSVKG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRGX","BK4139"],"gpt_icon":0},{"id":"2507663103","title":"CARGO Therapeutics Inc - Phase 1 Study Enrollment for Crg-023 to Start in Q2 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2507663103","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507663103?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUAWSVKG:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2507166316","title":"CARGO Therapeutics Inc - to Reduce Workforce by Approximately 50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2507166316","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507166316?lang=en_us&edition=fundamental","pubTime":"2025-01-30 05:05","pubTimestamp":1738184701,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250129:nTUAWSVKG:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["CRGX","BK4139"],"gpt_icon":0},{"id":"2503648421","title":"CARGO Therapeutics, Inc. (CRGX) Receives a Buy from Truist Financial","url":"https://stock-news.laohu8.com/highlight/detail?id=2503648421","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503648421?lang=en_us&edition=fundamental","pubTime":"2025-01-15 20:46","pubTimestamp":1736945160,"startTime":"0","endTime":"0","summary":"Truist Financial analyst Asthika Goonewardene maintained a Buy rating on CARGO Therapeutics, Inc. (CRGX – Research Report) today. The company’s sha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/cargo-therapeutics-inc-crgx-receives-a-buy-from-truist-financial-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/cargo-therapeutics-inc-crgx-receives-a-buy-from-truist-financial-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","CRGX"],"gpt_icon":0},{"id":"2503537144","title":"William Blair Keeps Their Buy Rating on CARGO Therapeutics, Inc. (CRGX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2503537144","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2503537144?lang=en_us&edition=fundamental","pubTime":"2025-01-14 03:45","pubTimestamp":1736797512,"startTime":"0","endTime":"0","summary":"William Blair analyst Sami Corwin maintained a Buy rating on CARGO Therapeutics, Inc. (CRGX – Research Report) today. The company’s shares opened t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-cargo-therapeutics-inc-crgx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/william-blair-keeps-their-buy-rating-on-cargo-therapeutics-inc-crgx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CRGX"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":62,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/CRGX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-12","symbol":"CRGX","fiscalQuarterEnding":"2024/12","expectedEps":-0.95,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1741752000000,"reportTimeType":"post","actualEps":-0.95},{"market":"US","date":"2024-11-12","symbol":"CRGX","fiscalQuarterEnding":"2024/09","expectedEps":-1.14,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731387600000,"reportTimeType":"post","actualEps":-0.88}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"CRGX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"CRGX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0,"hold":0.8333,"sell":0.1667,"strongSell":0,"meanLabel":"HOLD","meanPercent":0.8333,"analysts":6,"updateTime":1738296000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/CRGX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"CRGX","date":"2025-04-28","current":-1.239962,"percent":0.845238,"low":-16.638165,"twenty":-10.082677,"median":-6.053807,"eighty":-3.828079,"high":-1.012261,"avg":-6.465366,"sd":3.643579,"marketCap":207696179},"quantilePoints":[{"date":"2023-11-17","current":-10.065391,"twenty":-6.259806,"median":-5.188804,"eighty":-4.891423,"marketCap":570033298},{"date":"2023-11-24","current":-9.840047,"twenty":-10.028517,"median":-9.840047,"eighty":-5.180361,"marketCap":557271359},{"date":"2023-12-01","current":-10.208792,"twenty":-10.236107,"median":-9.952719,"eighty":-5.260568,"marketCap":578154532},{"date":"2023-12-06","current":-10.727768,"twenty":-10.535201,"median":-10.065391,"eighty":-6.214737,"marketCap":607545666},{"date":"2023-12-15","current":-8.22358,"twenty":-10.518812,"median":-10.003934,"eighty":-6.874766,"marketCap":656397912},{"date":"2023-12-22","current":-10.31432,"twenty":-10.535201,"median":-10.034662,"eighty":-7.979918,"marketCap":823278737},{"date":"2023-12-29","current":-11.728797,"twenty":-10.689527,"median":-10.106363,"eighty":-8.162665,"marketCap":936180826},{"date":"2024-01-05","current":-10.267859,"twenty":-10.708648,"median":-10.238326,"eighty":-8.779046,"marketCap":819570274},{"date":"2024-01-12","current":-10.830553,"twenty":-11.076726,"median":-10.31432,"eighty":-9.703366,"marketCap":864483879},{"date":"2024-01-19","current":-10.582761,"twenty":-10.970968,"median":-10.31432,"eighty":-9.840047,"marketCap":844705411},{"date":"2024-01-26","current":-11.620388,"twenty":-11.306323,"median":-10.519362,"eighty":-9.852338,"marketCap":927527746},{"date":"2024-02-02","current":-11.615226,"twenty":-11.615226,"median":-10.577599,"eighty":-9.91799,"marketCap":927115695},{"date":"2024-02-09","current":-12.167594,"twenty":-11.722602,"median":-10.633945,"eighty":-9.987932,"marketCap":971205196},{"date":"2024-02-16","current":-11.78042,"twenty":-11.722602,"median":-10.727768,"eighty":-10.016225,"marketCap":940301340},{"date":"2024-02-23","current":-11.759771,"twenty":-11.728797,"median":-11.006072,"eighty":-10.065391,"marketCap":938653134},{"date":"2024-03-01","current":-12.482496,"twenty":-11.826881,"median":-11.08818,"eighty":-10.066529,"marketCap":996340333},{"date":"2024-03-08","current":-16.638165,"twenty":-12.090159,"median":-11.26935,"eighty":-10.106363,"marketCap":1328041726},{"date":"2024-03-15","current":-14.500964,"twenty":-12.167594,"median":-11.372597,"eighty":-10.208792,"marketCap":1157452438},{"date":"2024-03-22","current":-10.086714,"twenty":-12.49282,"median":-11.398408,"eighty":-10.208792,"marketCap":989980757},{"date":"2024-03-28","current":-8.987804,"twenty":-12.484561,"median":-11.362272,"eighty":-10.082677,"marketCap":882125995},{"date":"2024-04-05","current":-8.530593,"twenty":-12.37925,"median":-11.209983,"eighty":-9.967446,"marketCap":837252116},{"date":"2024-04-12","current":-8.654922,"twenty":-12.204763,"median":-11.052532,"eighty":-9.622843,"marketCap":849454662},{"date":"2024-04-19","current":-7.660288,"twenty":-12.146945,"median":-10.918312,"eighty":-8.896361,"marketCap":751834293},{"date":"2024-04-26","current":-7.332459,"twenty":-12.133523,"median":-10.727306,"eighty":-8.526582,"marketCap":719658867},{"date":"2024-05-03","current":-8.407459,"twenty":-12.114939,"median":-10.585342,"eighty":-8.403209,"marketCap":825166841},{"date":"2024-05-10","current":-7.621265,"twenty":-12.094289,"median":-10.543395,"eighty":-8.235907,"marketCap":748004293},{"date":"2024-05-17","current":-6.932399,"twenty":-12.057121,"median":-10.444967,"eighty":-8.099171,"marketCap":840283050},{"date":"2024-05-24","current":-6.769972,"twenty":-11.908446,"median":-10.31432,"eighty":-7.90037,"marketCap":820595068},{"date":"2024-05-31","current":-6.065037,"twenty":-11.854758,"median":-10.267859,"eighty":-7.682381,"marketCap":735149229},{"date":"2024-06-07","current":-5.844136,"twenty":-11.833076,"median":-10.096539,"eighty":-7.640085,"marketCap":708373574},{"date":"2024-06-14","current":-5.581004,"twenty":-11.812427,"median":-10.06596,"eighty":-7.560664,"marketCap":676479044},{"date":"2024-06-21","current":-4.885815,"twenty":-11.78868,"median":-9.993933,"eighty":-7.012411,"marketCap":592214483},{"date":"2024-06-28","current":-5.917596,"twenty":-11.78455,"median":-9.942718,"eighty":-6.822598,"marketCap":717277770},{"date":"2024-07-05","current":-5.811655,"twenty":-11.77216,"median":-9.840047,"eighty":-6.688109,"marketCap":704436480},{"date":"2024-07-12","current":-6.507843,"twenty":-11.747381,"median":-9.612245,"eighty":-6.44292,"marketCap":788822100},{"date":"2024-07-15","current":-6.697024,"twenty":-11.741187,"median":-9.584778,"eighty":-6.464561,"marketCap":811752975},{"date":"2024-08-02","current":-6.318661,"twenty":-11.734992,"median":-9.557312,"eighty":-6.383443,"marketCap":765891225},{"date":"2024-08-09","current":-5.293297,"twenty":-11.728797,"median":-8.813341,"eighty":-6.210449,"marketCap":641605882},{"date":"2024-08-16","current":-5.09682,"twenty":-11.704018,"median":-8.618827,"eighty":-6.143003,"marketCap":752835997},{"date":"2024-08-23","current":-5.401386,"twenty":-11.648265,"median":-8.506529,"eighty":-5.916083,"marketCap":797822538},{"date":"2024-08-30","current":-5.528807,"twenty":-11.623485,"median":-8.407459,"eighty":-5.8306,"marketCap":816643438},{"date":"2024-09-06","current":-5.970117,"twenty":-11.617291,"median":-8.358136,"eighty":-5.813925,"marketCap":881828019},{"date":"2024-09-13","current":-6.837198,"twenty":-11.615226,"median":-8.231285,"eighty":-5.826809,"marketCap":1009901948},{"date":"2024-09-20","current":-7.769543,"twenty":-11.534693,"median":-8.154754,"eighty":-5.840238,"marketCap":1147615850},{"date":"2024-09-27","current":-5.746354,"twenty":-11.468616,"median":-8.013791,"eighty":-5.840238,"marketCap":848776682},{"date":"2024-10-04","current":-5.432464,"twenty":-11.423187,"median":-7.919003,"eighty":-5.809054,"marketCap":802413002},{"date":"2024-10-11","current":-5.842696,"twenty":-11.389116,"median":-7.795128,"eighty":-5.80028,"marketCap":863007119},{"date":"2024-10-18","current":-6.743963,"twenty":-11.370532,"median":-7.661377,"eighty":-5.809054,"marketCap":996130557},{"date":"2024-10-25","current":-6.402103,"twenty":-11.356077,"median":-7.651349,"eighty":-5.811655,"marketCap":945635460},{"date":"2024-10-31","current":-6.576141,"twenty":-11.318908,"median":-7.62674,"eighty":-5.813168,"marketCap":971342055},{"date":"2024-11-08","current":-6.678699,"twenty":-11.221857,"median":-7.520985,"eighty":-5.822612,"marketCap":986490584},{"date":"2024-11-15","current":-5.076236,"twenty":-11.139901,"median":-7.452526,"eighty":-5.813168,"marketCap":782471359},{"date":"2024-11-22","current":-4.697012,"twenty":-11.09531,"median":-7.250537,"eighty":-5.765001,"marketCap":724016145},{"date":"2024-11-29","current":-5.428587,"twenty":-11.048402,"median":-7.088931,"eighty":-5.678865,"marketCap":836784076},{"date":"2024-12-06","current":-5.109082,"twenty":-11.026721,"median":-6.975496,"eighty":-5.587572,"marketCap":787534408},{"date":"2024-12-13","current":-4.461116,"twenty":-10.970968,"median":-6.90557,"eighty":-5.557912,"marketCap":687654241},{"date":"2024-12-20","current":-4.034115,"twenty":-10.809996,"median":-6.83409,"eighty":-5.517618,"marketCap":621834591},{"date":"2024-12-27","current":-4.446186,"twenty":-10.727768,"median":-6.828089,"eighty":-5.432464,"marketCap":685352855},{"date":"2025-01-03","current":-4.493962,"twenty":-10.727398,"median":-6.817071,"eighty":-5.426198,"marketCap":692717291},{"date":"2025-01-10","current":-4.24015,"twenty":-10.698903,"median":-6.783525,"eighty":-5.405116,"marketCap":653593723},{"date":"2025-01-17","current":-3.583226,"twenty":-10.624741,"median":-6.743963,"eighty":-5.321308,"marketCap":552332724},{"date":"2025-01-24","current":-4.132653,"twenty":-10.585858,"median":-6.678699,"eighty":-5.278672,"marketCap":637023741},{"date":"2025-01-31","current":-1.012261,"twenty":-10.580696,"median":-6.631183,"eighty":-5.195136,"marketCap":156033994},{"date":"2025-02-07","current":-1.104828,"twenty":-10.563917,"median":-6.588572,"eighty":-5.14681,"marketCap":170302589},{"date":"2025-02-14","current":-1.101842,"twenty":-10.540557,"median":-6.521755,"eighty":-5.08447,"marketCap":169842312},{"date":"2025-02-21","current":-1.101842,"twenty":-10.529525,"median":-6.512107,"eighty":-4.919769,"marketCap":169842312},{"date":"2025-02-28","current":-1.086912,"twenty":-10.479441,"median":-6.501553,"eighty":-4.854077,"marketCap":167540926},{"date":"2025-03-07","current":-1.143646,"twenty":-10.38423,"median":-6.385332,"eighty":-4.757008,"marketCap":176286194},{"date":"2025-03-14","current":-1.135487,"twenty":-10.359749,"median":-6.318661,"eighty":-4.504673,"marketCap":190196279},{"date":"2025-03-21","current":-1.151983,"twenty":-10.306872,"median":-6.288196,"eighty":-4.446783,"marketCap":192959421},{"date":"2025-03-28","current":-1.146484,"twenty":-10.275235,"median":-6.215634,"eighty":-4.377507,"marketCap":192038374},{"date":"2025-04-04","current":-1.127239,"twenty":-10.256046,"median":-6.186804,"eighty":-4.225817,"marketCap":188814708},{"date":"2025-04-11","current":-1.11899,"twenty":-10.188306,"median":-6.162494,"eighty":-4.103987,"marketCap":187433137},{"date":"2025-04-17","current":-1.275704,"twenty":-10.106363,"median":-6.065037,"eighty":-4.034115,"marketCap":213682987},{"date":"2025-04-25","current":-1.244086,"twenty":-10.086714,"median":-6.053807,"eighty":-3.840023,"marketCap":208386965},{"date":"2025-04-28","current":-1.239962,"twenty":-10.082677,"median":-6.053807,"eighty":-3.828079,"marketCap":207696179}],"updateTime":1745973269252}}}